Q3 2022

Filed May 13, 2022 · 10-Q · 43 days after period end · 0000862668-22-000007

Q3 2022 · 10-Q

Revenue

$2.42M

+3.9% vs Q3 2021

Net Income

-$320.72K

N/M vs Q3 2021

EPS Diluted

-$0.04

N/M vs Q3 2021

Operating Income-$291,913N/M

Operating Cash Flow

Same quarter

Metric	Q3 2022	Q3 2021	Q3 2020	Q3 2019
Revenue	$2.42M	$2.32M	$2.36M	$2.67M
Net Income	-$320.72K	-$137.47K	-$127.88K	$22.21K
EPS Diluted	-$0.04	-$0.02	-$0.02	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR